CorMedix Inc. (CRMD) Social Stream



CorMedix Inc. (CRMD): $4.14

0.03 (+0.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRMD to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

CORMEDIX INC (CRMD) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRMD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 2 $29 $27 $28 $4.53 518.1%
2022-05-12 1 $29 $27 $28 $4.53 518.1%
2022-08-09 3 $27 $14 $20.5 $4.53 352.54%
2022-08-12 3 $16 $12 $14 $4.53 209.05%
2022-10-18 3 $18 $12 $14.666 $4.53 223.75%
2022-11-11 3 $18 $13 $15 $4.53 231.13%

The Trend in the Analyst Price Target


CRMD's average price target has moved down $5.3 over the prior 16 months.

Over the past 32 weeks, CRMD's average upside potential has been 494.24%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-29 1 29 27 28.000 5.54 405.42%
2022-05-12 1 29 27 28.000 2.98 839.6%
2022-08-09 3 27 12 17.666 3.20 452.06%
2022-08-12 3 16 12 14.000 4.15 237.35%
2022-11-11 3 18 13 15.000 3.71 304.31%

CRMD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 2 1 0 0 0 3

The Trend in the Broker Recommendations


CRMD's average broker recommendation rating improved by 0.67 over the prior 13 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CRMD has a greater number of analysts covering the stock than 57.16% of all US stocks.
  • In terms of how CORMEDIX INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 811.37% of that group.
  • CRMD has a lower variance in analysts' estimates than -146.77% of Pharmaceutical Products stocks.
  • CRMD has a higher average analyst price target than 325.42% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CORMEDIX INC are MDVL, SLS, and ATNM.

Is CRMD a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6574 seconds.